Diagnostic Imaging Equipment Market Share

North America Market Insights

North America is expected to maintain its dominance in the diagnostic imaging equipment market by capturing the largest share of 38.3% throughout the discussed period. The aging population and rapid AI adoption are the primary drivers behind the region's proprietorship in this sector. For instance, in 2023 alone, the FDA provided clearance for 45 new AI-enhanced imaging tools. In addition, the region witnessed a 30.4% increase in outpatient imaging from 2020 to 2024, which was supported by the expansion of telehealth reimbursements by the CMS. Besides, the number of new cancer cases in North America crossed 2.0 million in 2024, and 40.3% of them required advanced imaging, according to the CDC. Thus, demand for diagnostic technologies in the region continues to surge.

The U.S. is actively strengthening its position in the regional diagnostic imaging equipment market with substantial government investments and domestic production initiatives. In this regard, the Medical Device Development Tools (MDDT) program allocated $120.4 million to accelerate regulatory approvals and boost local manufacturing. Additionally, the HHS dedicated $250.1 million to escalating the domestic capabilities in imaging technologies under the ARPA-H initiative. However, the U.S. is still reliant on imports, sourcing $4.9 billion worth of imaging components in 2023 alone, where 32% of MRI magnets came from China, as reported by the U.S. International Trade Commission (USITC).

The diagnostic imaging equipment market in Canada is prioritizing equitable access and cost efficiency, which is backed by provincial allocations. For instance, between 2023 and 2024, the governing body of Ontario invested approximately $1.2 billion in expanding rural MRI availability. According to the Canadian Institute for Health Information (CIHI), with a current average 25-day waiting timeline for CT scans, the federal government aims to reduce delays by 50.4% by the end of 2030, which fosters new opportunities for product innovation. Furthermore, the efforts toward the enhancement of patient access and compliance underscore its potential to create lucrative avenues in this sector.

APAC Market Insights

Asia Pacific is anticipated to be the fastest-growing region in the global diagnostic imaging equipment market during the analyzed tenure. The rising healthcare investments, enlarging demography, and rapid healthcare modernization are propelling demand in this landscape. Particularly, emerging economies, such as China, India, and Malaysia, are fostering lucrative business opportunities for this merchandise as they are heavily investing in the expansion of healthcare infrastructure. Besides, government-backed initiatives and awareness campaigns for early disease detection are cultivating a sustainable consumer base, attracting both domestic and foreign MedTech pioneers to invest in this sector.

China dominates the APAC diagnostic imaging equipment market on account of strong government participation and a vast patient population. As per the National Medical Products Administration (NMPA), in 2023 alone, the imaging industry of the country saw by 15.4% YoY increase in equipment procurement, reaching $5.9 billion. On the other hand, AI-powered systems acquired over 30.4% of new installations, reflecting the nation's commitment to the rapid adoption of cutting-edge technology. Additionally, in 2023, the NMPA gave approval for AI-based imaging tools rose by 25.4%, cementing the forefront position for China in this category for the upcoming years.

India is emerging as the growth engine for the regional diagnostic imaging equipment market. The accelerated progress of the country in this sector is highly stimulated by its 2.5 million patients undergoing imaging procedures in 2023. This surge is also a result of favorable government initiatives, such as Ayushman Bharat. The nation is further solidifying its pace of propagation through public-private partnerships and widespread awareness about early diagnosis, particularly for affordable solutions. Utilizing this opportunity, GE Healthcare deployed 500 low-cost CT units in partnership with Narendra Modi Hospital and introduced a $250.3 thousand portable ultrasound for clinics in India.

Government Investments & Policies

Europe Market Insights

Europe is projected to sustain its position as the second-largest shareholder in the global diagnostic imaging equipment market between 2025 and 2034. The region's advanced healthcare infrastructure, strong government funding, and rapid adoption of innovative technologies are cultivating a progressive business atmosphere for this sector. Till 2023, the landscape was spearheaded by Germany, the UK, and France, which collectively accounted for over 60.2% of imaging revenue, as reported by the European Commission. The €1.9 billion allocation by Horizon Europe to next-gen imaging solutions is also securing a steady capital influx in support of this cohort of innovation. As evidence, in 2024, AI-powered radiology tools were being used in 30.4% of hospitals across Europe, according to the European Medicines Agency (EMA).

Germany is maintaining its dominance over the Europe diagnostic imaging equipment market. This is highly attributed to the rising CVD prevalence, reaching 8.3 million in 2025 alone, as per the Robert Koch Institute (RKI). Besides, 30.4% of the country’s population is over 60 and requires regular imaging, reinforcing its position as the foremost hub for cutting-edge diagnostic technology in Europe. The country's leadership is further backed by a notable increase in high-field MRI and PET-CT adoption, with over 12,004 operational imaging units and a 12.1% surge in MRI installations in 2024, according to a report from the Federal Ministry of Health.

The UK diagnostic imaging equipment market is witnessing steady growth, supported by continuous government and private spending. For instance, from 2020 to 2023, the expenditure on this category by the National Health Service (NHS) investments rose by 6.6%, totaling £2.5 billion. This extension in financial backing indicates the growing demand in this sector, with more than 4.8 million patients awaiting diagnostic procedures in 2024, as recorded by the Association of the British Pharmaceutical Industry (ABPI). The UK is also emerging as a regional leader in AI-powered radiology, with 40.2% of hospitals already adopting AI-based imaging tools, according to the Department of Health and Social Care.

Country-wise Government Provinces